| Neuropathy in Parkinson disease: prevalence and determinants. | |
| | |
MedLine Citation:
|
PMID: 22049200 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To ascertain the prevalence and determinants of neuropathy in patients with Parkinson disease (PD), in particular, the roles of vitamin B12 and levodopa exposure. METHODS: We performed a cross-sectional study of 37 patients with PD and 37 age- and gender-matched controls, using a sensitive and validated neuropathy scale. The prevalence of neuropathy was determined and compared between groups. We then ascertained the role of vitamin B12 by a separate case-control analysis (1) comparing numbers of patients in whom the neuropathy was directly attributable to vitamin B12 deficiency and (2) comparing serum vitamin B12 levels in patients with PD with neuropathy with a second control group consisting of age- and gender-matched consecutive patients with neuropathy without PD. We also determined correlations between cumulative levodopa exposure, PD duration, neuropathy status and score, and vitamin B12 status and levels in all patients with PD and, specifically, in those with neuropathy. RESULTS: Fourteen of 37 (37.8%) patients with PD and 3 of 37 (8.1%) control subjects had neuropathy (p = 0.005), corresponding to an odds ratio (95% confidence interval) for neuropathy, of 6.9 (1.78-26.73). Vitamin B12 deficiency was a significantly more common cause of neuropathy (p = 0.024) and vitamin B12 levels were significantly lower (p = 0.002) in patients with PD with neuropathy than in age- and gender-matched consecutive control subjects with neuropathy without PD. Cumulative levodopa exposure correlated with PD duration (p = 0.001) and vitamin B12 levels (p = 0.044), in patients with PD with neuropathy. CONCLUSIONS: Neuropathy is more prevalent in patients with PD than in control subjects. This may be predominantly due to vitamin B12 deficiency, which could relate to cumulative levodopa exposure in susceptible individuals. Vitamin B12 monitoring and supplementation, as well as serial clinical assessment for neuropathy, may be advisable in patients with PD. |
| | |
Authors:
|
Yusuf A Rajabally; Jean Martey |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2011-11-02 |
Journal Detail:
|
Title: Neurology Volume: 77 ISSN: 1526-632X ISO Abbreviation: Neurology Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-29 Completed Date: 2012-01-25 Revised Date: 2012-05-15 |
Medline Journal Info:
|
Nlm Unique ID: 0401060 Medline TA: Neurology Country: United States |
Other Details:
|
Languages: eng Pagination: 1947-50 Citation Subset: AIM; IM |
Affiliation:
|
Neuromuscular Clinic, Department of Neurology, University Hospitals of Leicester, Leicester General Hospital, Leicester LE5 4PW, UK. yusuf.rajabally@uhl-tr.nhs.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Case-Control Studies Cohort Studies Comorbidity / trends Cross-Sectional Studies Female Humans Male Middle Aged Parkinson Disease / diagnosis, drug therapy, epidemiology* Peripheral Nervous System Diseases / diagnosis, epidemiology* Prevalence Vitamin B 12 Deficiency / blood, chemically induced*, epidemiology* |
| Comments/Corrections | |
Comment In:
|
Mov Disord. 2012 Apr;27(4):474 Neurology. 2011 Nov 29;77(22):e132-4 [PMID: 22123787 ] Neurology. 2011 Nov 29;77(22):1938-9 [PMID: 22049202 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Motivations for Anabolic Steroid use Among Bodybuilders.
Next Document: Pentanucleotide repeats at the spinocerebellar ataxia type 31 (SCA31) locus in Caucasians.